109 related articles for article (PubMed ID: 20079437)
21. Expression profiling of macrophages from subjects with atherosclerosis to identify novel susceptibility genes.
Hägg DA; Jernås M; Wiklund O; Thelle DS; Fagerberg B; Eriksson P; Hamsten A; Olsson B; Carlsson B; Carlsson LM; Svensson PA
Int J Mol Med; 2008 Jun; 21(6):697-704. PubMed ID: 18506362
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
23. Global gene expression changes underlying Stachybotrys chartarum toxin-induced apoptosis in murine alveolar macrophages: evidence of multiple signal transduction pathways.
Wang H; Yadav JS
Apoptosis; 2007 Mar; 12(3):535-48. PubMed ID: 17186382
[TBL] [Abstract][Full Text] [Related]
24. Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis.
Achiron A; Gurevich M
Autoimmun Rev; 2006 Oct; 5(8):517-22. PubMed ID: 17027885
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility.
Fornage M; Swank MW; Boerwinkle E; Doris PA
Physiol Genomics; 2003 Sep; 15(1):75-83. PubMed ID: 12902546
[TBL] [Abstract][Full Text] [Related]
26. Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.
Lindberg RL; De Groot CJ; Certa U; Ravid R; Hoffmann F; Kappos L; Leppert D
J Neuroimmunol; 2004 Jul; 152(1-2):154-67. PubMed ID: 15223248
[TBL] [Abstract][Full Text] [Related]
27. HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review.
Minagar A; Shapshak P; Duran EM; Kablinger AS; Alexander JS; Kelley RE; Seth R; Kazic T
J Neurol Sci; 2004 Sep; 224(1-2):3-17. PubMed ID: 15450765
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
29. Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.
Reinhold WC; Kouros-Mehr H; Kohn KW; Maunakea AK; Lababidi S; Roschke A; Stover K; Alexander J; Pantazis P; Miller L; Liu E; Kirsch IR; Urasaki Y; Pommier Y; Weinstein JN
Cancer Res; 2003 Mar; 63(5):1000-11. PubMed ID: 12615715
[TBL] [Abstract][Full Text] [Related]
30. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
[TBL] [Abstract][Full Text] [Related]
31. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
Weinstock-Guttman B; Bhasi K; Badgett D; Tamaño-Blanco M; Minhas M; Feichter J; Patrick K; Munschauer F; Bakshi R; Ramanathan M
J Neuroimmunol; 2008 Dec; 205(1-2):113-25. PubMed ID: 18950872
[TBL] [Abstract][Full Text] [Related]
32. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis.
Utz U; Biddison WE; McFarland HF; McFarlin DE; Flerlage M; Martin R
Nature; 1993 Jul; 364(6434):243-7. PubMed ID: 7686632
[TBL] [Abstract][Full Text] [Related]
33. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.
Lundmark F; Duvefelt K; Iacobaeus E; Kockum I; Wallström E; Khademi M; Oturai A; Ryder LP; Saarela J; Harbo HF; Celius EG; Salter H; Olsson T; Hillert J
Nat Genet; 2007 Sep; 39(9):1108-13. PubMed ID: 17660816
[TBL] [Abstract][Full Text] [Related]
34. Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions.
Satoh J; Obayashi S; Misawa T; Tabunoki H; Yamamura T; Arima K; Konno H
Neuropathology; 2008 Dec; 28(6):561-76. PubMed ID: 18410276
[TBL] [Abstract][Full Text] [Related]
35. Kinin B1 receptor expression on multiple sclerosis mononuclear cells: correlation with magnetic resonance imaging T2-weighted lesion volume and clinical disability.
Prat A; Biernacki K; Saroli T; Orav JE; Guttmann CR; Weiner HL; Khoury SJ; Antel JP
Arch Neurol; 2005 May; 62(5):795-800. PubMed ID: 15883268
[TBL] [Abstract][Full Text] [Related]
36. Risk alleles for multiple sclerosis in multiplex families.
D'Netto MJ; Ward H; Morrison KM; Ramagopalan SV; Dyment DA; DeLuca GC; Handunnetthi L; Sadovnick AD; Ebers GC
Neurology; 2009 Jun; 72(23):1984-8. PubMed ID: 19506219
[TBL] [Abstract][Full Text] [Related]
37. An array of sunshine in multiple sclerosis.
Dyment DA; Ebers GC
N Engl J Med; 2002 Oct; 347(18):1445-7. PubMed ID: 12409550
[No Abstract] [Full Text] [Related]
38. Susceptibility to multiple sclerosis: interplay between genes and environment.
Willer CJ; Ebers GC
Curr Opin Neurol; 2000 Jun; 13(3):241-7. PubMed ID: 10871246
[TBL] [Abstract][Full Text] [Related]
39. cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity.
Mycko MP; Papoian R; Boschert U; Raine CS; Selmaj KW
Brain; 2003 May; 126(Pt 5):1048-57. PubMed ID: 12690045
[TBL] [Abstract][Full Text] [Related]
40. Large-scale gene-expression studies and the challenge of multiple sclerosis.
Baranzini SE; Hauser SL
Genome Biol; 2002 Sep; 3(10):reviews1027. PubMed ID: 12372148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
